SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹288 Cr | ₹385 Cr | ₹457 Cr | ₹330 Cr | ₹383 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹385 Cr |
| Mar2023 | ₹457 Cr |
| Mar2022 | ₹330 Cr |
| Mar2021 | ₹383 Cr |
How is Cash Flow from Operating Activities of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | -25.11 | |
| Mar2024 | ₹385 Cr | -15.84 | |
| Mar2023 | ₹457 Cr | 38.54 | |
| Mar2022 | ₹330 Cr | -13.74 | |
| Mar2021 | ₹383 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹20,363.9 Cr | -0.1% | -5.4% | -52.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -0.1% |
-5.4% |
-52.7% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses